, 16, 73; H. Sakahara and T. Saga, Adv, Drug Delivery Rev, vol.37, p.689, 1999.

, Anal. Chem, p.1841, 1990.

, Bioconjugate Chem, p.869, 2006.

K. L. Christman, M. V. Requa, V. D. Enriquez-rios, S. C. Ward, K. A. Bradley et al., Langmuir, p.7444, 2006.

T. T. Nguyen, K. L. Sly, and J. C. Conboy, Technical data sheet 779; (c) Pierce Biotechnology. Instructions for neutravidin, Anal. Chem, vol.84, p.31000, 0201.

A. G. Cheetham, M. G. Hutchings, T. D. Claridge, and H. L. Anderson, For representative examples of ( pseudo)rotaxane-like molecules interacting with proteins see: (a), vol.45, p.6730, 1596.

A. Nelson, J. M. Belitsky, S. Vidal, C. S. Joiner, L. G. Baum et al., J. Inclusion Phenom. Mol. Recognit. Chem, vol.126, p.233, 2004.

T. Higashi, F. Hirayama, H. Arima, and K. Uekama, Bioorg. Med. Chem. Lett, 1871.

J. Geng, F. Biedermann, J. M. Zayed, F. Tian, O. A. Scherman-;-k et al., J. Am. Chem. Soc, p.4445, 2010.

J. M. Chinai, A. B. Taylor, L. M. Ryno, N. D. Hargreaves, C. A. Morris et al., J. Am. Chem. Soc, p.646, 2005.

X. J. Loh, M. H. Tsai, J. D. Barrio, E. A. Appel, T. Lee et al., Polym. Chem, vol.3, p.3180, 2012.

A. Fernandes, A. Viterisi, F. Coutrot, S. Potoc, D. A. Leigh et al., Phys. Chem. Chem. Phys, vol.48, p.12229, 2003.

B. Odell, M. V. Reddington, A. M. Slawin, N. Spencer, J. F. Stoddart et al., Angew. Chem., Int. Ed. Engl, p.1547, 1988.

E. Katz, L. Sheeney-haj-ichia, I. T. Willner-;-b)-s, G. Caldwell, A. Cooke et al., Angew. Chem., Int. Ed, vol.43, p.2650, 2004.

M. Asakawa, W. Dehaen, G. L'abbé, S. Menzer, J. Nouwen et al., J. Org. Chem, p.9591, 1996.

P. L. Anelli, P. R. Ashton, R. Ballardini, V. Balzani, M. Delgado et al., For representative examples see, Angew. Chem., Int. Ed. Engl, vol.114, p.6819, 1131.

L. Scarpantonio, A. Tron, C. Destribats, P. Godard, and N. D. Mcclenaghan, Chem. Commun, p.3981, 2012.

R. Ballardini, V. Balzani, M. T. Gandolfi, L. Prodi, M. Venturi et al., For examples of previous reports of pseudorotaxane formation of 1 in aqueous conditions see: (a), vol.32, p.301, 1032.

, A recent computational study has indicated that the associated colour change following complexation of TTF by macrocycle 1 does not necessarily indicate pseudorotaxane formation, Chem.-Eur J, vol.18, p.5606, 2012.

A. Credi, M. Montalti, V. Balzani, S. J. Langford, F. M. Raymo et al., New J. Chem, p.1061, 1998.

T. Huberman, Y. Eisenberg-domovich, G. Gitlin, T. Kulik, E. A. Bayer et al., J. Biol. Chem, p.32031, 2001.

S. Repo, T. A. Paldanius, V. P. Hytönen, T. K. Nyholm, K. K. Halling et al., Chem. Biol, p.1029, 2006.

P. C. Weber, J. J. Wendoloski, M. W. Pantoliano, and F. R. Salemme, J. Am. Chem. Soc, vol.114, p.3197, 1992.

C. A. Lackey, N. Murthy, O. W. Press, D. A. Tirrell, A. S. Hoffman et al., Bioconjugate Chem, p.401, 1999.

, The inevitable uncertainties in absolute concentrations of active binding species prevent a more unambiguous statement of binding stoichiometry

S. Ke, J. C. Wright, and G. S. Kwon, Bioconjugate Chem, 2007.

H. J. Gruber, M. Marek, H. Schindler, and K. Kaiser, Bioconjugate Chem, vol.8, p.552, 1997.

L. O. Brown, Y. Gao, C. Wang, H. Wang, S. K. Doorn et al., For an example of biotin-avidin-mediated decomplexation see: B. C. Satishkumar, Nano, issue.2, p.560, 2007.

P. R. Ashton, J. Huff, S. Menzer, I. W. Parsons, J. A. Preece et al., J. Chem. Soc., Chem. Commun, vol.26, p.885, 1584.

P. R. Ashton, V. Balzani, J. Becher, A. Credi, M. C. Fyfe et al., J. Am. Chem. Soc, p.3951, 1999.

, A very pale pink colour was observed when >10 equivalents of macrocycle 1 was added to the solution of the neutra-vidin·3 complex indicating that a low-affinity complex may form

, Avidin structure image adapted from the RCSB PDB, p.5076, 1993.

E. R. Kay, D. A. Leigh, and F. Zerbetto, Angew. Chem., Int. Ed, vol.46, p.72, 2007.